GH and IGF1 in cancer therapy resistance

Despite landmark advances in cancer treatments over the last 20 years, cancer remains the second highest cause of death worldwide, much ascribed to intrinsic and acquired resistance to the available therapeutic options. In this review, we address this impending issue, by focusing the spotlight on th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Endocrine-related cancer 2023-09, Vol.30 (9), p.1
Hauptverfasser:	Basu, Reetobrata, Kopchick, John J
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapies Growth factors Growth Hormone - metabolism Growth hormones Human Growth Hormone - therapeutic use Humans Insulin-like growth factor I Insulin-Like Growth Factor I - metabolism Neoplasms - drug therapy Thematic Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!